Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
James Metz, MD

James Metz, MD Physician

Chair, Department of Radiation Oncology Henry K. Pancoast Professor of Radiation Oncology

Dr. Metz is employed by Penn Medicine.

About Dr. James Metz

Recognized by America's Top Doctors 2015 – 2017

Recognized in Philadelphia magazine's annual Top Docs issue, 2011 to 2018

Calypso, Medical Advisory Board

Pennsylvania Cancer Education Network Advisory Committee

ProCure Proton Treatment Centers Medical Advisory Board

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Radiation Oncology

Programs & Centers:

Board Certification:

  • Radiation Oncology, 2000

Clinical Expertise:

  • Anal Cancer
  • Bile Duct Cancer (Cholangiocarcinoma)
  • Colon Cancer
  • Esophageal Cancer
  • Gallbladder Cancer
  • Gastrointestinal Carcinoid Tumor
  • Liver Cancer
  • Neuroendocrine Tumors
  • Pancreatic Cancer
  • Proton Therapy
  • Radiation Treatment
  • Rectal Cancer
  • Small Intestine Cancer
  • Stomach Cancer (Gastric Cancer)

Description of Clinical Expertise

Dr. Metz serves as Chair of Radiation Oncology at the Perelman School of Medicine and holds the Henry K. Pancoast Endowed Professorship. He is Associate Director for Clinical Services and Programs at the Abramson Comprehensive Cancer Center of the University of Pennsylvania. Dr. Metz led the development of the Roberts Proton Therapy Center, the largest proton center in the world completely integrated with conventional cancer services. Dr. Metz has become an international leader in the application of proton therapy for the treatment of a variety of malignancies. He continues to work to integrate proton therapy as a new treatment paradigm for cancer and is leading the expansion of proton therapy.

Dr. Metz specializes in the use of radiation for the treatment of gastrointestinal malignancies. His research interests include the treatment of GI malignancies in the multidisciplinary setting, as well as the utilization of complementary and alternative medications by cancer patients, and use of the Internet to provide cancer related information. A major area of interest has been the development of proton therapy at Penn and internationally.

Dr. Metz also serves as Executive Director of OncoLink (www.oncolink.upenn.edu), the award winning Internet resource from the Abramson Comprehensive Cancer Center of the University of Pennsylvania that was founded in 1994. As Executive Director, Dr. Metz leads OncoLink’s mission to help cancer patients, families, health care professionals, and the general public find accurate cancer-related information online. The website has led the way in online education for cancer patients and healthcare providers, receiving numerous awards and recognition from most major authorities as one of the best cancer information websites. Currently OncoLink is developing interactive content and personalized information for individuals while collecting important information to move the field forward, particularly in the area of cancer survivorship. Its reach is international in scope with over 285,000 unique visitors served per month.

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Vetrans Choice Program (6/2018 Not Active)

Education and Training

Medical School: University of Medicine and Dentistry of New Jersey
Residency: Cooper University Hospital
Residency: University of Pennsylvania School of Medicine

Memberships

American Society of Clinical Oncology, National American Society of Therapeutic Radiology and Oncology, National Calypso, Medical Advisory Board, National Pennsylvania Cancer Education Network Advisory Committee, Local

Hospital Affiliation

Dr. Metz is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Szalda D1, 2, Schapira MM3, Jacobs LA1, Palmer SC1, Vachani C4, Metz J4, Hill-Kayser C2, 4.: Survivorship Care Planning for Young Adults After Cancer Treatment:Preliminary Understanding Care Patterns and Patient-Reported Outcomes. J Adolesc Young Adult Oncol. 7 (4): 430-437,2018.

Benci JL1, Vachani CC1, Bach C1, Arnold-Korzeniowski K1, Hampshire MK1, Metz JM1, Hill-Kayser CE2.: Identifying barriers to cancer survivors sharing their survivorship care plans with their healthcare provider. J Cancer Surviv. : 2018.

Frick M, Vachani C, Bach C, Arnold-Korzienowski K, Hampshire M, Metz JM, Hill-Kayser CE:: Patient-Reports of Fatigue and Cognitive Changes in Cancer Survivors. Gerontology & Geriatric Medicine 4 (1): 1-5,2018.

Baumann BC1, 2, 3, Wei J4, Plastaras JP1, Lukens JN1, Damjanov N5, Hoteit M6, Hsu C6, Levine M7, Mondschein J8, Nadolski G8, Olthoff K7, Reiss KA5, Rosen M9, Siegelman E9, Metz JM1, Ben-Josef E1.: Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity. Am J Clin Oncol. : 2018.

Guttmann DM, Mitra N, Metz JM, Plastaras J, Feng W, Swisher-McClure S.: Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer. J Geriatr Oncol. 9 (1): 40-46,2018.

Boimel PJ, Berman AT, Li J, Apisarnthanarax S, Both S, Lelionis1 K, Larson GL, Teitelbaum U, Lukens JN, Ben-Josef E, Metz JM, Plastaras JP: Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma Journal of Gastrointestinal Oncology : 2017.

Baumann BC, Zeng C, Freedman GM, Verginadis II, MacArthur KM, Lin LL, Vachani C, Koumenis C, Solberg TD, Metz JM: Avoiding antiperspirants during breast radiation therapy: Myth or sound advice? Radiother Oncol : 2017.

Frick MA, Vachani CC, Bach C, Hampshire MK, Arnold-Korzeniowski K, Metz JM, Hill-Kayser CE: Survivorship and the chronic cancer patient: Patterns in treatment-related effects, follow-up care, and use of survivorship care plans. Cancer : 2017.

Frick MA, Vachani CC, Hampshire MK, Bach C, Arnold-Korzeniowski K, Metz JM, Hill-Kayser CE.: Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for care. Cancer : 2017.

Guttmann DM, Mitra N, Bekelman J, Metz JM, Plastaras J, Feng W, Swisher-McClure S: Improved overall survival with aggressive primary tumor radiotherapy for patients with metastatic esophageal cancer Journal of Thoracic Oncology : 2017.

Academic Contact Info

Perelman Center for Advanced Medicine
3400 Civic Center Blvd
2 West

Philadelphia, PA 19104
Phone: (215) 662-2428
Patient appointments: 800-789-7366 (PENN)

Related Links